Article Information
History
- February 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Ville-Petteri Mäkinen1,2,3,4,*,
- Jacqueline Rehn5,6,
- James Breen6,7,8,
- David Yeung5,6,9,10 and
- Deborah L White5,6,9,11,12
- 1Computational and Systems Biology Program, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
- 2Australian Centre for Precision Health, University of South Australia, Adelaide, Australia
- 3Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland
- 4Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
- 5Blood cancer Program, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
- 6Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
- 7South Australian Genomics Centre, South Australian Health and Medical Research Institute, Adelaide, Australia
- 8Robinson Research Institute, University of Adelaide, Adelaide, Australia
- 9Australian and New Zealand Children’s Oncology Group, Clayton, Victoria, Australia
- 10Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
- 11Faculty of Sciences, University of Adelaide, Adelaide, Australia
- 12Australian Genomics Health Alliance, Parkville, Victoria, Australia
- ↵*Corresponding author
Ville-Petteri Mäkinen South Australian Health and Medical Research Institute North Terrace, SA 5000, Adelaide, Australia Tel. +61 8 8128 4054 Email: ville-petteri.makinen{at}sahmri.com
Posted February 19, 2022.
